| SR. NO | TEST | TEST COMPONENTS | Method | Specimen/Transport | TAT | Clinical Applications |
|---|---|---|---|---|---|---|
| 1 | Troponin I | CLIA | Serum | 2Hrs | Myocardial infaraction | |
| 2 | CK-MB | CLIA | Serum | 4Hrs | Myocardial infaraction | |
| 3 | Homocysteine | CLIA | Serum | 4Hrs | Cardiac risk predictor | |
| 4 | Myoglobin | CLIA | Serum | 4Hrs | Myocardial infarction, myopathies. | |
| 5 | Fibrinogen degradation product | Latex agglutination | Citrate Plasma | 4Hrs | DIC, DVT, PE | |
| 6 | D-Dimer | CLIA | Citrate Plasma | 4Hrs | DIC, DVT, PE | |
| 7 | PF4 Antibody | Gel Card | Serum | 4Hrs | Heparin-induced thrombocytopenia (HIT-II) | |
| 8 | NT proBNP | CLIA | EDTA | 4Hrs | Acute congestive heart failure | |
| 9 | Lipid Index | Lipid profile + Lipoprotein A, Apolipoprotein A1+B | EZYMATIC + IMMUNOTURBIDIMETRY | Serum | 4Hrs | Myocardial infarction |
| 10 | HsCRP | Nephelometry | Serum | 4Hrs | Myocardial infarction |